Estimates Revisions Emcure Pharmaceuticals Limited

Stocks

End-of-day quote NSE India S.E. Other stock markets 2026-08-03			5-day change	1st Jan Change
1,969.70 ^INR	+0.49%		+4.72%	+44.35%

07-21	Emcure Pharmaceuticals Limited Announces Cessation of P.S. Jayakumar as Independent Director and from Board Committees, Effective July 21, 2026	CI
07-20	Emcure Pharmaceuticals Limited completed the acquisition of an additional unknown minority stake in Gennova Biopharmaceuticals Ltd. from Sanjay Singh.	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	EMCURE PHARMACEUTICALS LIMITED
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	NOVO NORDISK A/S
	AMGEN INC.
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.